Spots Global Cancer Trial Database for cancer of the pancreas
Every month we try and update this database with for cancer of the pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | NCT04331041 | Pancreas Cancer Cancer of the P... Pancreas Adenoc... | Adaptive stereo... Defactinib Tumor biopsy Research blood ... | 18 Years - | Washington University School of Medicine | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | NCT02608229 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | BVD-523 Nab-paclitaxel Gemcitabine Tumor biopsy | 18 Years - | Washington University School of Medicine | |
| CAR T Cell Immunotherapy for Pancreatic Cancer | NCT03323944 | Pancreatic Canc... Cancer of the P... | huCART-meso cel... | 18 Years - | University of Pennsylvania | |
| Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction | NCT03821025 | Bile Duct Obstr... Cancer of the P... Cancer of the B... Biliary Strictu... | Biliary stent | 18 Years - | University of Cape Town | |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | NCT00116389 | Pancreatic Canc... Neoplasm Metast... Adenocarcinoma | talabostat mesy... gemcitabine | 18 Years - | Point Therapeutics | |
| Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | NCT03956056 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Neoantigen Pept... Poly ICLC Blood for immun... | 18 Years - | Washington University School of Medicine | |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer | NCT01313416 | Pancreatic Neop... Cancer of the P... Neoplasms Pancr... Pancreatic Canc... Pancreas Cancer | CT-011 Gemcitabine | 18 Years - | Augusta University | |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies | NCT02950025 | Pancreatic Canc... Pancreas Cancer Cancer of the P... Hepatocellular ... | Online, adaptiv... Online, non-ada... European Organi... | 18 Years - | Washington University School of Medicine | |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | NCT02311361 | Pancreatic Neop... Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Durvalumab Tremelimumab Sterostatic bod... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery | NCT05111353 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Optimized neoan... Poly-ICLC | 18 Years - | Washington University School of Medicine | |
| Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | NCT03122106 | Pancreatic Canc... Pancreas Cancer Cancer of the P... | Personalized ne... TDS-IM Electrod... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | NCT02352831 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Tosedostat Capecitabine Fresh tissue bi... | 18 Years - | Washington University School of Medicine | |
| A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | NCT04123574 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreatic Canc... | Talabostat Mesy... | 18 Years - 75 Years | BioXcel Therapeutics Inc | |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | NCT04542291 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Dapagliflozin BIOSENSE meters | 18 Years - | Washington University School of Medicine | |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies | NCT02950025 | Pancreatic Canc... Pancreas Cancer Cancer of the P... Hepatocellular ... | Online, adaptiv... Online, non-ada... European Organi... | 18 Years - | Washington University School of Medicine | |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | NCT02608229 | Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | BVD-523 Nab-paclitaxel Gemcitabine Tumor biopsy | 18 Years - | Washington University School of Medicine | |
| Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients | NCT04536077 | Pancreatic Canc... Cancer of the P... Pancreas Cancer | CDX-301 CDX-1140 Research blood ... | 18 Years - | Washington University School of Medicine | |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer | NCT01313416 | Pancreatic Neop... Cancer of the P... Neoplasms Pancr... Pancreatic Canc... Pancreas Cancer | CT-011 Gemcitabine | 18 Years - | Augusta University | |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | NCT04542291 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Dapagliflozin BIOSENSE meters | 18 Years - | Washington University School of Medicine | |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | NCT04331041 | Pancreas Cancer Cancer of the P... Pancreas Adenoc... | Adaptive stereo... Defactinib Tumor biopsy Research blood ... | 18 Years - | Washington University School of Medicine | |
| Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint | NCT00613730 | Cancer of Pancr... Cancer of the P... Pancreas Cancer Pancreatic Canc... | Gemcitabine panitumumab | 18 Years - 75 Years | Amgen | |
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
| Epidural Analgesia Use in Pancreatic Resections | NCT02681796 | Cancer of Pancr... Cancer of the P... Pancreas Cancer Pancreas Neopla... Pancreatic Canc... | Bupivacaine | 18 Years - | Washington University School of Medicine | |
| ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | NCT00102700 | Pancreatic Canc... Adenocarcinoma | ARQ 501 in comb... | 18 Years - | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
| Safety and Efficacy Study of 90Y-hPAM4 at Different Doses | NCT00597129 | Pancreatic Canc... | 90Y-hPAM4 | 18 Years - | Gilead Sciences | |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | NCT02905578 | Pancreatic Neop... Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... Adenocarcinoma | Gemcitabine nab-paclitaxel Pharmacological... | 18 Years - | University of Iowa | |
| Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer | NCT00603863 | Pancreatic Canc... | IMMU-107 (hPAM4... | 18 Years - | Gilead Sciences | |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies | NCT02950025 | Pancreatic Canc... Pancreas Cancer Cancer of the P... Hepatocellular ... | Online, adaptiv... Online, non-ada... European Organi... | 18 Years - | Washington University School of Medicine | |
| Trial of Curcumin in Advanced Pancreatic Cancer | NCT00094445 | Pancreatic Neop... Adenocarcinoma | Curcumin | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Efficacy Study of 90Y-hPAM4 at Different Doses | NCT00597129 | Pancreatic Canc... | 90Y-hPAM4 | 18 Years - | Gilead Sciences | |
| Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy | NCT01484860 | Adenocarcinoma ... Metastatic Dise... | AUY922 | 18 Years - | University Health Network, Toronto | |
| Diet and Exercise After Pancreatic Cancer | NCT03187028 | Pancreatic Canc... | Diet Only Diet + Exercise | 18 Years - | University of Alabama at Birmingham | |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | NCT02311361 | Pancreatic Neop... Pancreatic Canc... Cancer of Pancr... Cancer of the P... Pancreas Cancer | Durvalumab Tremelimumab Sterostatic bod... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer | NCT00603863 | Pancreatic Canc... | IMMU-107 (hPAM4... | 18 Years - | Gilead Sciences | |
| A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas | NCT01838317 | Cancer of the P... | Pioglitazone | 18 Years - | University of Texas Southwestern Medical Center | |
| Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction | NCT03821025 | Bile Duct Obstr... Cancer of the P... Cancer of the B... Biliary Strictu... | Biliary stent | 18 Years - | University of Cape Town | |
| Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy | NCT02830620 | Cancer of the P... Anorexia | Dosage of chimi... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery | NCT05111353 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Optimized neoan... Poly-ICLC | 18 Years - | Washington University School of Medicine | |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | NCT00116389 | Pancreatic Canc... Neoplasm Metast... Adenocarcinoma | talabostat mesy... gemcitabine | 18 Years - | Point Therapeutics | |
| CAR T Cell Immunotherapy for Pancreatic Cancer | NCT03323944 | Pancreatic Canc... Cancer of the P... | huCART-meso cel... | 18 Years - | University of Pennsylvania |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
